Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Using Decamethoxine and Blastomunil together speeds up wound healing.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Axitinib treatment turned a man's grey hair back to black.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Imatinib can cause hair loss due to lichen planopilaris.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.